Course Overview
Our team of medical marijuana professionals has developed a state-of-the-art eLearning program for cannabis education online. Our online courses are certified by Washington state and can be used as credits for Washington State Medical Marijuana Consultant Certification, along with the annual state-required Continuing Education courses to maintain certification.
Cannabis education online courses can also be purchased by anybody looking to expand their knowledge on a myriad of medicinal cannabis topics.
As we continue to expand our advanced cannabis education and learning management system, we are creating a “knowledge vault” where students can continually access new information. Additional modules are being developed to help the patient, the consultant and the independent learner gain a greater understanding of cannabis, cannabis related science, substance abuse, communication skills, professional ethics and ailments, as well as state-specific medical marijuana laws and policies.
Credibility and Standards
MM411 certifications are designed to ensure that individuals and organizations meet specific standards of knowledge and competence in the field of medical cannabis. These certifications help establish credibility among healthcare providers, industry workers (budtenders) patients, and the medical community.
Comprehensive Education
The certification process typically involves comprehensive educational programs that cover various aspects of medical cannabis, including its medical uses, legal regulations, dosing, how to medicate, and potential interactions with other medications. This enables certified individuals to provide accurate and informed guidance to patients.
Enhanced Patient Care
By obtaining an MM411 certification, healthcare professionals and budtenders can enhance their ability to support patients effectively. This certification provides them with the tools and knowledge necessary to help patients navigate their medical cannabis journey, leading to improved treatment outcomes and overall patient satisfaction.
Reviews
MM411 Beyond Stigma: Fundamentals of Psychedelic-Assisted Medicine is essential for several reasons:
- Comprehensive Knowledge: The certification program provides essential knowledge about the safe handling, storage, and distribution of marijuana products. This understanding is crucial for complying with Alaska’s regulations and ensuring the quality and safety of cannabis products.
- Regulatory Compliance: Certification through Medical Marijuana 411 helps ensure that individuals are familiar with the specific laws and regulations governing psychedelic medicine. Being knowledgeable about these regulations is essential for maintaining compliance, which can help prevent legal issues and sanctions.
- Enhanced Professionalism: Having a MM411 certification demonstrates a commitment to professionalism and a higher standard of care within the cannabis industry. This can build trust with customers, and employers, reinforcing your credibility as a handler of marijuana.
- Consumer Safety: With the certification, individuals learn about the importance of proper customer interactions, including accurately answering questions about product effects, dosing, and potential interactions, as well as knowing proper checks for identification.
Course Description & Syllabus
Psychedelic-assisted therapy has the potential to revolutionize mental healthcare.
We believe the greatest barriers to this revolution are stigma and misinformation. We also believe education is the most powerful tool to combat those barriers.
In service to this mission, we have collated the highly compelling evidence-based data emerging from psychedelic science to create this comprehensive course.
Who is This Course For?
- Anyone interested in the therapeutic benefits of psychedelics
- Medical and health professionals
- Patients and their loved ones
- Advocates
Module 1: Introduction
Mental health disorders are one of the leading causes of disability in the world – 1 in 4 people will experience at least one mental health disorder in their lifetime.
Below are some global statistics to get a sense of the prevalence of this issue:
- Over 300 million people suffer from major depressive disorders – one-third are resistant to treatment
- About 35 million people struggle with substance use disorders
- 6-9% of the population suffers from PTSD
- Of the 40 million people requiring palliative care each year, 29-50% will suffer from death-related anxiety and depression
- Approximately 16 million people suffer from eating disorders8, and prevalence rates are spiking, rising from 3.5%to 7.8% between 2000 and 2018
Module 2: The Role of Music In Mediating Therapeutic Outcomes in Psychedelic Therapy
In psychedelic research, there is a consensus amongst independent research groups that the effectiveness of clinical trials using psychedelics such as psilocybin is mediated by the occurrence of personally meaningful experiences during the session, including “peak-experiences” and “autobiographical insight”.
Music is a key component of all psychedelic therapies and plays an essential role in successful therapeutic outcomes. Psychedelics and music are thought to work synergistically: psychedelics enhance the subjective experience of music significantly, and music is shown to play a key role in facilitating these personally meaningful experiences.
Module 3: The Historical Landscape of Psychedelics
- The ancient history of psychedelic use
- The pre-prohibition history of psychedelics (pre-1970s)
- The prohibition era
- The post-prohibition period of psychedelic research
- Introduction to the Psychedelic Renaissance
Module 4: An Overview of Psychedelic Substances
- The definition of psychedelics and types used in psychedelic-assisted therapy
- The effects of different psychedelics on the brain
- A structured breakdown of prominent psychedelic substances, including LSD, psilocybin, mescaline, ayahuasca/DMT, MDMA, ketamine, and ibogaine
- The safety profile of psychedelics, including harm scores and addictive potential
- The legal landscape of psychedelics
Module 5: An Overview of Psychedelic-Assisted Therapy
This module will briefly review how psychedelic-assisted therapy works and some main factors in the therapeutic process.
Although various approaches can be found in underground settings, we will focus on the process used in the clinical trials, which will be outlined in upcoming modules.
- A background on early theories of psychedelic-assisted therapy
- An overview of what modern psychedelic-assisted therapy entails, including:
- The importance of set and setting
- Screening criteria
- Preparatory therapy sessions
- Psychedelic-assisted therapy sessions and the psychedelic experience – Integrative therapy sessions
Module 7: Psychedelic Medicine for the Treatment of Addiction
- Background to addiction, including the current treatments (both medical and non-drug interventions) and where they fall short
- A review of the psychedelic compounds being researched and a detailed discussion of the up-to-date literature with a focus on the controlled/randomized clinical trials for addiction
- Possible contraindications to psychedelic-assisted treatment
Module 8: Psychedelic Medicine for the Treatment of Depression
- Background to depression, including the current treatments (both medical and non-drug interventions) and where they fall short
- A review of the psychedelic compounds being researched and a detailed discussion of the up-to-date literature with a focus on the controlled/randomized clinical trials for this condition
- Possible contraindications to psychedelic-assisted treatment
Module 9: Psychedelic Medicine for the Treatment of End of Life Distress in Palliative Care
- Background to end of life distress in palliative care, including the current treatments (both medical and non-drug interventions) and where they fall short
- A review of the psychedelic compounds being researched and a detailed discussion of the up-to-date literature with a focus on the controlled/randomized clinical trials for this condition
- Possible contraindications to psychedelic-assisted treatment
- Forthcoming research exploring psychedelics for end of life distress in palliative care
Sandra F. –
Very educational … I truly enjoyed each segment.
Anton M. –
It is so awesome to know that my personal experience relates to what professionals have discovered. It is really powerful.
Sonja C. –
The written content of the course was well organized and easy to follow. Thank you for all your good work and for access to this information.
Bavly N. –
Really great insightful and enjoyable!
Helen J. –
I loved the integrative approach and the background literature to deepen my knowledge is fantastic. Your team did a marvelous job.
Elena S. –
Very informative, interesting course which is well organized, summarizing the details, emphasizing the main points, known researches and materials, and underlining the psychiatry achievements in the field.
Robin E. –
Well done team!!!
Lauren Y. –
_
M. T. –
_
Brittany O. –
_
Lola O. –
_
Madeline M. –
_
Sylvia M. –
_
Jennifer L. –
_
John J. –
_
Andi G. –
_
Allison E. –
_
Wil D. –
_
BRUCE B. –
_
Will A. –
_
Only logged in customers who have purchased this product may leave a review.